The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models.
about
Monocytes in atherosclerosis: subsets and functionsTargeting T cells to treat atherosclerosis: odyssey from bench to bedsideHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisRegulation of atherogenesis by chemokines and chemokine receptorsThe ubiquitin-proteasome system and cardiovascular diseaseRegulation of atherogenesis by chemokine receptor CCR6Role of CX3CR1 receptor in monocyte/macrophage driven neovascularizationNestin(+) cells direct inflammatory cell migration in atherosclerosis.Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysisEndoplasmic reticulum stress and atherosclerosisCXCL5 limits macrophage foam cell formation in atherosclerosisMonocytes link atherosclerosis and cancerOX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularizationCombined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting StentSelenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesisImpaired lipid levels and inflammatory response in rats exposed to cadmiumGenetics and beyond--the transcriptome of human monocytes and disease susceptibilityMonocyte recruitment during infection and inflammationMouse models of atherosclerosis: a historical perspective and recent advances.Neutrophil lymphocyte ratio in peripheral vascular disease: a review.B cell subsets in atherosclerosis.Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosisInterleukin 17 in vascular inflammation.CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.Molecular imaging of inflammation in atherosclerosis.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors.Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisOxidative risk for atherothrombotic cardiovascular disease.On to the road to degradation: atherosclerosis and the proteasomeIncreased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activationThe synergistic effect of homocysteine and lipopolysaccharide on the differentiation and conversion of raw264.7 macrophagesDeficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileInnate and adaptive immunity in atherosclerosis.Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils.Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.Suppressive effect of insulin infusion on chemokines and chemokine receptors
P2860
Q22251045-10F8B5C2-8AA0-4337-BB78-843D6949D133Q26740179-38B852B3-7052-4B2C-B373-DE26EE3C8E59Q26774658-A6529E83-08F0-4AED-9033-C79B7D821577Q26991813-B70A11F1-4D56-40BC-B86E-D3E2A86A27D9Q26996707-3BF04B95-A275-452A-A9D3-838E1D5CEC7DQ27003124-B67B483D-DB2A-429F-AEC1-AFD06566E1ACQ27021582-652D1016-7033-42F1-B334-E2B459FCFECBQ27023950-1845AC29-F04C-43AB-AD07-BFE23C9F647DQ27313463-131A87F9-D9D0-4093-9588-6D513C7388FCQ27329117-EFC06217-B1F6-4FF7-8B18-5A0D4342459BQ28264081-22110847-D041-4C80-A3B0-1E704521656AQ28279152-21296CA4-13EC-4F47-A2C2-DBF66BD9B733Q28284807-89B3C120-06CF-42F8-A475-F17045767149Q28390589-1D6130C0-9C5B-4788-9EBE-8F0198008963Q28506359-155D768D-B964-40EA-ABD6-5A9CBC36FE38Q28546788-D19434E7-DE3E-4CB1-8B1C-D6C824C6543FQ28588228-C45CA252-5D62-45AF-909D-47506527C671Q28596181-ED912ECE-D0F7-4A19-B5D0-46F65D91D986Q28752094-FAABC85A-DF51-4F02-9E23-EB08CE9DEF5BQ29620067-6842B218-EA89-4B86-B401-15C20002D4D6Q30238973-A75AB6DC-C541-4A4E-B081-4BC92EAAD434Q30251802-4C052860-14D5-4EDD-A648-C9C3E5BEA8FBQ30423324-CDF70161-9244-43C5-BD0C-FF5DB666856DQ30425368-F8C1347A-1088-4DE4-82A0-BE085885FEF5Q30429445-56C027DD-B0C1-4945-A223-FBAC94248483Q30433527-BA7014C2-E13D-4606-9FDF-54E402CBB2B9Q30446268-B7AE851D-393E-450C-828F-6B5F41C83954Q30497499-AD0DE0C0-6057-4D37-83F0-3A18B71942D8Q33450605-16B0BE90-46EB-4E8F-82F3-4EED8C004EE1Q33513370-AB09C7D0-B355-4590-8D56-C2E5572444A1Q33554184-AD2C4B44-AC48-4400-AB41-3DB1816A1A55Q33554513-A072BC9A-C318-4679-B90D-54D9E750821FQ33597485-F3434356-E571-41FE-8B0B-91BA72A55AC1Q33646582-A818CAAA-3FA0-4B01-8400-B0B7B2BD11DEQ33656103-A975A8AD-C490-4E8A-ABAA-A021CF58320EQ33659705-821E8884-EE77-4268-84E7-350F96B788BEQ33710719-C82DF387-530C-47B6-91F8-73D6ED76E1E5Q33802771-5DDC94F5-5391-44DF-B6E2-5D21AC7BAC31Q33803709-65BF88D4-C8B2-457D-88B9-5488516142B2Q33804698-F5E6A46D-616B-4E31-A9B0-333FCD0FBAD5
P2860
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The multifaceted contributions ...... is: lessons from mouse models.
@en
The multifaceted contributions ...... is: lessons from mouse models.
@nl
type
label
The multifaceted contributions ...... is: lessons from mouse models.
@en
The multifaceted contributions ...... is: lessons from mouse models.
@nl
prefLabel
The multifaceted contributions ...... is: lessons from mouse models.
@en
The multifaceted contributions ...... is: lessons from mouse models.
@nl
P50
P356
P1476
The multifaceted contributions ...... is: lessons from mouse models.
@en
P304
P356
10.1038/NRI2415
P577
2008-10-01T00:00:00Z